World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000021041
Date of registration: 15/02/2016
Prospective Registration: Yes
Primary sponsor: Second department of Internal Medicine, Shimane University Faculty of Medicine
Public title: A study investigating the therapeutic effect of vonoprazan on the patients with proton pump inhibitor resistant eosinophilic esophagitis
Scientific title: A study investigating the therapeutic effect of vonoprazan on the patients with proton pump inhibitor resistant eosinophilic esophagitis - A study investigating the therapeutic effect of vonoprazan on the patients with proton pump inhibitor resistant eosinophilic esophagitis
Date of first enrolment: 2016/02/15
Target sample size: 5
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024280
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name: Norihisa    Ishimura
Address:  89-1, Enya-cho, Izumo, Shimane Japan
Telephone: 0853-20-2190
Email: ishimura@med.shimane-u.ac.jp
Affiliation:  Shimane University Faculty of Medicine Second department of Internal Medicine
Name: Norihisa    Ishimura
Address:  89-1, Enya-cho, Izumo, Shimane 693-8501 Japan
Telephone: 0853-20-2190
Email: ishimura@med.shimane-u.ac.jp
Affiliation:  Shimane University Faculty of Medicine Second department of Internal Medicine
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1)Patients with advanced malignant disease 2)Patients who are administrated the drug which affects their condition 3)Patients who are not eligible for participation judged by a resercher

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Eosinophilic esophagitis
Intervention(s)
administration of Vonoprazan (20mg/day for 2 months)
Primary Outcome(s)
improvement of esophageal eosinophilia after administration for 2 months
Secondary Outcome(s)
symptom improvement
Secondary ID(s)
Source(s) of Monetary Support
Second department of Internal Medicine, Shimane University Faculty of Medicine
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date: 25/01/2016
Contact:
kenkyu@med.shimane-u.ac.jp
Clinical Research Center, Shimane University Hospital
0853-20-2515
kenkyu@med.shimane-u.ac.jp
Results
Results available: Yes
Date Posted:
Date Completed: 30/09/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history